An Orally Efficacious Thyrotropin Receptor Ligand Inhibits Growth and Metastatic Activity of Thyroid Cancers.
Sarkar R, Bolel P, Kapoor A, Eliseeva E, Dulcey AE, Templin JS, Wang AQ, Xu X, Southall N, Klubo-Gwiezdzinska J, Neumann S, Marugan JJ, Gershengorn MC.
Sarkar R, et al. Among authors: wang aq.
J Clin Endocrinol Metab. 2024 Feb 29:dgae114. doi: 10.1210/clinem/dgae114. Online ahead of print.
J Clin Endocrinol Metab. 2024.
PMID: 38421044